University of Leicester and Leicester General Hospital, Leicester, United Kingdom.
J Urol. 2011 Dec;186(6):2310-5. doi: 10.1016/j.juro.2011.07.078. Epub 2011 Oct 20.
We examined the clinical effectiveness of a single incision sling in women with stress urinary incontinence and obtained comparative perioperative and postoperative data on retropubic and transobturator slings.
Women who underwent a cough stress test were treated with surgery using a single incision, retropubic or obturator sling (Gynecare® TVT SECUR™, TVT™ or TVT Obturator System, respectively) with the choice of sling based on surgeon preference. Objective cure was assessed by the standing cough stress test at 1 year. Subjective outcomes were assessed by the Incontinence Quality of Life Questionnaire and EQ-5D™. Perioperative data and return to normal activity were recorded.
Of the 1,398 women who underwent surgery there were postoperative data on 1,334, including 32.8%, 17.8% and 49.4% who received a tension free vaginal tape, obturator tension free vaginal tape and SECUR, respectively. After obturator tension free vaginal tape surgery fewer women had a positive cough stress test than after TVT and SECUR surgery (4 of 110 or 3.6% vs 24 of 187 or 12.8% and 59 of 374 or 15.8%, respectively). Incontinence Quality of Life Questionnaire effect size was 1.87, 1.42 and 1.56, respectively, indicating a large treatment effect. Using our Incontinence Quality of Life Questionnaire response definition 85.4%, 79.0% and 85.2% of the TVT, TVT outside-in obturator system and SECUR cohorts, respectively, were treatment responders (p = 0.11).The SECUR cohort had the shortest operative time, the lowest proportion of women who required an overnight stay and the most women who underwent surgery under local anesthesia. Median time to return to employment, housework, sex life and hobbies was most rapid for SECUR.
This registry demonstrates the high effectiveness of all 3 approaches. The single incision sling appeared to have objective and subjective efficacy similar to that of the retropubic sling and it can be performed under local anesthesia in an office environment.
我们研究了单一切口吊带术治疗压力性尿失禁患者的临床疗效,并获得了经耻骨后和经闭孔吊带术的围手术期和术后的比较数据。
接受咳嗽压力测试的女性接受了单一切口、耻骨后或闭孔吊带术(Gynecare® TVT SECUR™、TVT™ 或 TVT 闭孔系统)治疗,吊带术的选择基于外科医生的偏好。1 年后通过站立咳嗽压力测试评估客观治愈率。通过尿失禁生活质量问卷和 EQ-5D™ 评估主观结果。记录围手术期数据和恢复正常活动情况。
在接受手术的 1398 名女性中,有 1334 名女性的术后数据完整,其中分别有 32.8%、17.8%和 49.4%的患者接受了无张力阴道吊带术、闭孔无张力阴道吊带术和 SECUR 治疗。与 TVT 和 SECUR 手术相比,接受闭孔无张力阴道吊带术的女性中,咳嗽压力测试阳性的女性更少(110 例中有 4 例,3.6%;187 例中有 24 例,12.8%;374 例中有 59 例,15.8%)。尿失禁生活质量问卷的效应大小分别为 1.87、1.42 和 1.56,表明治疗效果较大。使用我们的尿失禁生活质量问卷的反应定义,TVT、TVT 外侧入闭孔系统和 SECUR 队列的分别有 85.4%、79.0%和 85.2%的患者为治疗应答者(p = 0.11)。SECUR 队列的手术时间最短,需要过夜的女性比例最低,接受局部麻醉手术的女性最多。SECUR 患者恢复工作、家务、性生活和爱好的中位时间最快。
该注册研究表明这 3 种方法均具有较高的有效性。单一切口吊带术似乎具有与耻骨后吊带术相似的客观和主观疗效,并且可以在办公室环境下进行局部麻醉。